Update shared on 18 Dec 2025
Fair value Decreased 3.13%Analysts have trimmed their price target for Givaudan by CHF 100 to CHF 3,100. This reflects slightly softer assumptions for long term revenue growth and margins, even as they continue to view the company as relatively well positioned against intensifying competition and pricing pressures.
Analyst Commentary
Recent Street research presents a mixed picture for Givaudan. While some see the group as structurally well positioned, a series of price target reductions underscores lingering concerns about the pace and durability of its growth, as well as the valuation premium the shares continue to command.
Bearish analysts have trimmed their expectations for the stock, cutting price targets to the CHF 3,300 to CHF 3,725 range. These moves point to a more cautious stance on how quickly Givaudan can reaccelerate volumes and defend margins in the face of heightened competition and normalizing pricing tailwinds.
Even as select institutions move to a more positive rating, the gap between the most bullish and more conservative price targets highlights uncertainty around the earnings recovery trajectory and the appropriate multiple for the shares.
Bearish Takeaways
- Bearish analysts cite execution risk in restoring volume growth, arguing that recent momentum may not fully offset slowing demand in more mature end markets.
- Downward price target revisions reflect concerns that margin resilience could be tested by Chinese competition, tighter customer pricing negotiations, and input cost volatility.
- Some see the shares as still pricing in a robust medium term recovery, leaving limited room for disappointment if organic growth or cost savings underdeliver expectations.
- The clustering of targets closer to CHF 3,300 suggests a more conservative view on valuation, with bearish analysts reluctant to assign a higher multiple until visibility on sustainable growth improves.
Valuation Changes
- Fair value was reduced modestly from CHF 3,200 to CHF 3,100, implying a slightly lower intrinsic valuation for the shares.
- The discount rate edged down marginally from 4.54 percent to 4.51 percent, reflecting a slightly lower assumed cost of capital.
- Revenue growth was revised down from 2.95 percent to 2.68 percent, indicating a more conservative outlook for long term top line expansion.
- The net profit margin was trimmed slightly from 15.04 percent to 14.90 percent, signaling a minor reduction in expected profitability levels.
- The future P/E was lowered modestly from 26.58x to 26.18x, pointing to a small derating in the forward earnings multiple.
Have other thoughts on Givaudan?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
